Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lemaitre Vascular (LMAT) Non-cash Items (2016 - 2025)

Lemaitre Vascular (LMAT) has disclosed Non-cash Items for 15 consecutive years, with $13.6 million as the latest value for Q4 2025.

  • On a quarterly basis, Non-cash Items rose 3791.35% to $13.6 million in Q4 2025 year-over-year; TTM through Dec 2025 was $13.6 million, a 3791.35% increase, with the full-year FY2025 number at $13.6 million, up 3791.35% from a year prior.
  • Non-cash Items was $13.6 million for Q4 2025 at Lemaitre Vascular, up from $349981.0 in the prior quarter.
  • In the past five years, Non-cash Items ranged from a high of $13.9 million in Q4 2021 to a low of $349981.0 in Q4 2024.
  • A 5-year average of $7.2 million and a median of $7.9 million in 2022 define the central range for Non-cash Items.
  • Peak YoY movement for Non-cash Items: soared 4503.37% in 2021, then tumbled 95.47% in 2023.
  • Lemaitre Vascular's Non-cash Items stood at $13.9 million in 2021, then plummeted by 43.27% to $7.9 million in 2022, then crashed by 95.47% to $356519.0 in 2023, then decreased by 1.83% to $349981.0 in 2024, then soared by 3791.35% to $13.6 million in 2025.
  • Per Business Quant, the three most recent readings for LMAT's Non-cash Items are $13.6 million (Q4 2025), $349981.0 (Q4 2024), and $356519.0 (Q4 2023).